| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/28/2013 | CN103265548A Extraction method of dendrobine |
| 08/28/2013 | CN103263455A Preparation and application of medicine with neuroprotective effect |
| 08/28/2013 | CN102399230B N-acylpyrazole derris ether, its preparation method and application |
| 08/28/2013 | CN102174050B Method for separating and purifying coptis alkaloids by utilizing polyamide resin |
| 08/27/2013 | US8519149 Tricyclic compounds as mPGES-1 inhibitors |
| 08/27/2013 | US8518983 P38 inhibitors and methods of use thereof |
| 08/27/2013 | US8518955 Fused pyrimidineone compounds as TRPV3 modulators |
| 08/27/2013 | US8518901 Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| 08/27/2013 | CA2649741C Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/22/2013 | WO2013122823A1 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 08/22/2013 | WO2013122402A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/22/2013 | US20130217690 Novel 3-hydroxyisothiazole 1-oxide derivatives |
| 08/22/2013 | US20130217676 5ht2c receptor modulators |
| 08/22/2013 | US20130217672 (+)-3-hydroxymorphinan-based polycycle derivatives |
| 08/22/2013 | US20130217664 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/21/2013 | EP2627332A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 08/21/2013 | EP2543667A9 2-aminopyridine analogs as glucokinase activators |
| 08/21/2013 | CN103261201A 2-amino-4-arylthiazole compounds as TRPA1 antagonists |
| 08/21/2013 | CN103254891A Mercury ion fluorescence sensor as well as synthetic method and application thereof |
| 08/21/2013 | CN103254206A Separating and purifying method of camptothecin |
| 08/21/2013 | CN103254205A Spirocyclic derivatives as histone deacetylase inhibitors |
| 08/21/2013 | CN103254204A Icotinib hydrochloride crystal form pharmaceutical composition and purpose |
| 08/21/2013 | CN103254203A Five-membered urea ring-coumarin derivative or pharmaceutical salt and application thereof |
| 08/21/2013 | CN103254202A Preparation method of asenapine |
| 08/21/2013 | CN103254201A Preparation method of asenapine |
| 08/21/2013 | CN103254191A Substituted aryl tetracyclic antifungal compound as well as preparation method and application thereof |
| 08/21/2013 | CN103254118A Preparation method of Hg<2+> probe |
| 08/21/2013 | CN102241891B Pyrazolopyridine coumarin dye derivative, and synthesis method and application thereof |
| 08/21/2013 | CN102229615B Method for synthesizing 9-nitrocamptothecin |
| 08/21/2013 | CN102229614B Method for synthesizing 9-aminocamptothecin |
| 08/21/2013 | CN101851244B Substituted phenyl keto enols as pesticides and herbicides |
| 08/21/2013 | CN101824038B Camptothecin and method for preparing analogues thereof |
| 08/21/2013 | CN101193862B Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 08/20/2013 | US8513419 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
| 08/20/2013 | US8513270 Substituted heterocycles as Janus kinase inhibitors |
| 08/20/2013 | US8513232 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands |
| 08/15/2013 | US20130211099 Asenapine maleate |
| 08/15/2013 | US20130211081 Method for stereoselective synthesis of bicyclic heterocyclic compounds |
| 08/15/2013 | US20130211074 Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| 08/15/2013 | US20130210851 Crystalline forms of a hexahydrofuro[3,4-c]quinoline derivative |
| 08/15/2013 | US20130210850 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
| 08/15/2013 | US20130210837 Compounds and Their Use as BACE Inhibitors |
| 08/15/2013 | US20130210801 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| 08/15/2013 | US20130209494 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 08/14/2013 | EP2625181A2 Method of preparation of antiviral compounds and useful intermediates thereof |
| 08/14/2013 | EP2624698A1 FURO[3,2-d]PYRIMIDINE COMPOUNDS |
| 08/14/2013 | CN103249735A Tricyclic compounds and methds of making and using same |
| 08/14/2013 | CN103249728A Novel triazole compounds III |
| 08/14/2013 | CN103242825A Rhodamine 6G-based Cu<2+> fluorescence probe molecule and preparation method thereof |
| 08/14/2013 | CN103242332A 1-N acyl substituted indolone derivative |
| 08/14/2013 | CN103242331A Rhodamine 6GpH fluorescent molecular probe containing biphenyl group as well as preparation method and application thereof |
| 08/14/2013 | CN103242330A Phenylimidogenrhodamine 6G hydrogen ion probe compound as well as preparation method and application thereof |
| 08/14/2013 | CN103242329A 9-fluorene-N'-(rhodamine 6G-hydrazide)pH fluorescence molecular probe as well as preparation method and use thereof |
| 08/14/2013 | CN103242328A p-N-methyl acetamidophenyl rhodamine 6G pH fluorescence molecular probe as well as preparation method and use thereof |
| 08/14/2013 | CN103242327A P-N-methyl cyclopentaldehyde rhodamine 6G pH fluorescence molecular probe as well as preparation method and use thereof |
| 08/14/2013 | CN102285994B Method for separating and purifying fangchinoline and tetrandrine from stephania tetrandra |
| 08/14/2013 | CN101437816B 2-aminopyridine analogs as glucokinase activators |
| 08/13/2013 | US8507722 Hepatitis C virus inhibitors |
| 08/13/2013 | US8507669 Optically active dibenzazepine derivatives |
| 08/13/2013 | US8507520 Polysubstituted 2-aryl-6-phenylimidazo[1,2-A]pyridine derivatives, and preparation and therapeutic use thereof |
| 08/13/2013 | US8507487 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |
| 08/13/2013 | US8507476 Substituted arylamide diazepinopyrimidone derivatives |
| 08/13/2013 | CA2670892C Substituted diazepan compounds as orexin receptor antagonists |
| 08/13/2013 | CA2611892C Tetrahydroquinoline derivatives as motor protein eg5 inhibitors and antitumor agents |
| 08/08/2013 | WO2013116291A1 Imidazo [4, 5 - b] pyridine derivatives as alk and jak modulators for the treatment of proliferative disorders |
| 08/08/2013 | WO2013116228A1 Compounds and methods for inhibition of ap endonuclease-1/ redox factor-1 (hape1) activity |
| 08/08/2013 | WO2013113715A1 Fungicidal pyrimidine compounds |
| 08/08/2013 | WO2013093931A3 Novel prodrugs of phenolic drugs |
| 08/08/2013 | US20130203747 Inhibitors of human immunodeficiency virus replication |
| 08/08/2013 | US20130203737 Fused heterocyclic derivatives as s1p modulators |
| 08/08/2013 | US20130203730 Benzothiazoles as ghrelin receptor modulators |
| 08/08/2013 | US20130203727 Napht-2-ylacetic acid derivatives to treat aids |
| 08/07/2013 | EP2621932A1 Tetracyclic heterocycle compounds for treating hepatitis c viral infection |
| 08/07/2013 | EP2621929A1 Novel acridine derivatives |
| 08/07/2013 | EP2621898A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process |
| 08/07/2013 | EP2621493A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| 08/07/2013 | CN103232467A Kukoline structurally-reconstructed compound and preparation method thereof |
| 08/07/2013 | CN103232466A Preparation method of compound (I) 4-hydroxy substituted phenyl imine type rhodamine 6G fluorescence molecule probe and purpose thereof |
| 08/07/2013 | CN103232465A A preparation method and applications of a Schiff base compound of benzophenone rhodamine 6G hydrazide |
| 08/07/2013 | CN103232464A Paclitaxel-like compounds, and preparation method thereof and application thereof in anticancer mediciens |
| 08/07/2013 | CN103232463A Preparation method for glycobismine A |
| 08/07/2013 | CN103232462A Synthetic method of coumarin-pyrrole compound |
| 08/07/2013 | CN103232461A Synthesis method of 4-chloroquine anhydride |
| 08/07/2013 | CN102229613B New process for synthesis of asenapine |
| 08/07/2013 | CN101511841B Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors |
| 08/06/2013 | US8501770 Substituted imidazopyridinyl-aminopyridine compounds |
| 08/06/2013 | US8501767 Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors |
| 08/06/2013 | CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 08/06/2013 | CA2609388C Novel piperidine derivative |
| 08/01/2013 | WO2013112809A2 Rifaximin derivative and uses thereof |
| 08/01/2013 | WO2013112757A1 Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| 08/01/2013 | WO2013112622A1 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof |
| 08/01/2013 | WO2013110890A1 New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/01/2013 | WO2013110698A1 Substituted pyrano and furanoquinolines, their preparation and use as medicaments |
| 08/01/2013 | WO2013110135A1 Heterocyclic compounds and methods for their use |
| 08/01/2013 | WO2010120994A3 Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis |
| 08/01/2013 | US20130197217 1, 2, 4-triazolone derivative |
| 08/01/2013 | US20130197050 Novel lactams and uses thereof |
| 08/01/2013 | US20130197019 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |
| 08/01/2013 | US20130196998 Spiro-cyclic amine derivatives as s1p modulators |